ANEBULO PHARMACEUTICALS, INC. (ANEB) Financial Statements

ANEBULO PHARMACEUTICALS, INC. (ANEB) files with the U.S. Securities and Exchange Commission under CIK 0001815974. 10KGenie shows its annual and quarterly statements from SEC filings.

Key Figures, Fiscal Year 2025

Net Income
-$8.48 million
Total Assets
$12.15 million
Net Cash from Operations
-$6.35 million

Fiscal year ended Jun 30, 2025. Latest periodic SEC filing: Feb 12, 2026. Source: SEC filings (EDGAR XBRL).

Open the full financial statements for ANEB in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History